BlackRock’s ZELTIQ Aesthetics, Inc. ZLTQ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-4,407,573
| Closed | -$245M | – | 5193 |
|
|
2017
Q1 | $245M | Buy |
4,407,573
+4,404,355
| +136,866% | +$221M | 0.01% | 1123 |
|
|
2016
Q4 | $140K | Sell |
3,218
-47
| -1% | -$1.9K | ﹤0.01% | 2354 |
|
|
2016
Q3 | $128K | Buy |
3,265
+332
| +11% | +$11.9K | ﹤0.01% | 2456 |
|
|
2016
Q2 | $80K | Buy |
2,933
+753
| +35% | +$21.2K | ﹤0.01% | 2677 |
|
|
2016
Q1 | $60K | Buy |
2,180
+1,215
| +126% | +$28.6K | ﹤0.01% | 2276 |
|
|
2015
Q4 | $28K | Sell |
965
-253
| -21% | -$7.99K | ﹤0.01% | 2409 |
|
|
2015
Q3 | $40K | Sell |
1,218
-1,615
| -57% | -$53.5K | ﹤0.01% | 2013 |
|
|
2015
Q2 | $84K | Buy |
2,833
+1,612
| +132% | +$48.7K | ﹤0.01% | 1847 |
|
|
2015
Q1 | $38K | Sell |
1,221
-392
| -24% | -$12.5K | ﹤0.01% | 2071 |
|
|
2014
Q4 | $45K | Buy |
1,613
+415
| +35% | +$10.8K | ﹤0.01% | 1991 |
|
|
2014
Q3 | $27K | Buy |
1,198
+476
| +66% | +$9.43K | ﹤0.01% | 2193 |
|
|
2014
Q2 | $11K | Buy |
722
+322
| +81% | +$5.5K | ﹤0.01% | 2749 |
|
|
2014
Q1 | $8K | Hold |
400
| – | – | ﹤0.01% | 2891 |
|
|
2013
Q4 | $8K | Sell |
400
-68,100
| -99% | -$973K | ﹤0.01% | 2884 |
|
|
2013
Q3 | $618K | Buy |
+68,500
| New | +$508K | ﹤0.01% | 1197 |
|
Other funds holding ZLTQ
BlackRock's ZLTQ Position: Q2 2017 in Review
BlackRock sold out of ZELTIQ Aesthetics, Inc. (ZLTQ) in Q2 2017, closing a stake of 4,407,573 shares — an estimated $245M sold.
BlackRock first reported a position in ZLTQ in Q3 2013 and held it in 15 quarters. The position peaked at $245M in Q1 2017. 2 funds tracked by Wall St. Rank hold ZLTQ as of Q2 2017.
- BlackRock reported no remaining ZELTIQ Aesthetics, Inc. position as of Q2 2017 after selling out during the quarter.
- BlackRock sold 4,407,573 ZELTIQ Aesthetics, Inc. shares in Q2 2017, an estimated $245M.
- BlackRock first reported a position in ZELTIQ Aesthetics, Inc. in Q3 2013 and held it in 15 quarters.
- BlackRock's ZELTIQ Aesthetics, Inc. position peaked at $245M in Q1 2017.
- 2 funds tracked by Wall St. Rank held ZELTIQ Aesthetics, Inc. as of Q2 2017.
Based on BlackRock's 13F filing for Q2 2017, filed 10 Aug 2017.